BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 4141904)

  • 21. Localization of the oxidative defect in phytanic acid degradation in patients with Refsum's disease.
    Mize CE; Herndon JH; Blass JP; Milne GW; Follansbee C; Laudat P; Steinberg D
    J Clin Invest; 1969 Jun; 48(6):1033-40. PubMed ID: 4181594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.
    Yao JK; Dyck PJ
    Lipids; 1987 Feb; 22(2):69-75. PubMed ID: 2436023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heredopathia atactica polyneuritiformis (Refsum's Disease): a second trial of dietary therapy in two patients.
    Kark RA; Engel WK; Blass JP; Steinberg D; Walsh GO
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):53-5. PubMed ID: 4141911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
    Watkins PA; Mihalik SJ
    Biochem Biophys Res Commun; 1990 Mar; 167(2):580-6. PubMed ID: 1690986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heredopathia atactica polyneuritiformis (Refsum's disease).
    Cervós-Navarro J
    Histol Histopathol; 1990 Oct; 5(4):439-50. PubMed ID: 1724932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in sterol and phospholipid fatty acid composition in Refsum's disease fibroblasts grown in the presence of phytol.
    Friedman KJ; Shapiro SS
    Clin Physiol Biochem; 1985; 3(5):249-56. PubMed ID: 2414050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the phytol metabolism in lipoidosis heredopathia atactica polyneuritiformis (Refsum's syndrome). The transformation of 3H-phytol into the 3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) of the plasma lipoid fractions].
    Kahlke W; Wagener H; Dieckmann H
    Klin Wochenschr; 1965 Dec; 43(24):1345-7. PubMed ID: 4163289
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biochemical study of Refsum's disease].
    Sezille G; Biserte G
    Pathol Biol (Paris); 1970 May; 18(9):551-8. PubMed ID: 4192793
    [No Abstract]   [Full Text] [Related]  

  • 29. Separation and characterization of phytanic acid-containing plasmatriglycerides from a patient with Refsum's disease.
    Laurell S
    Biochim Biophys Acta; 1968 Jan; 152(1):75-9. PubMed ID: 4171423
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the biochemical defect in heredopathia atactica polyneuritiformis (Refsum's disease).
    Eldjarn L; Try K; Stokke O
    Pathol Eur; 1968; 3(2):459-67. PubMed ID: 4176999
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata.
    ten Brink HJ; Schor DS; Kok RM; Stellaard F; Kneer J; Poll-The BT; Saudubray JM; Jakobs C
    Pediatr Res; 1992 Nov; 32(5):566-70. PubMed ID: 1282700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.
    Wierzbicki AS; Lloyd MD; Schofield CJ; Feher MD; Gibberd FB
    J Neurochem; 2002 Mar; 80(5):727-35. PubMed ID: 11948235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid.
    Skjeldal OH; Stokke O
    Scand J Clin Lab Invest; 1988 Feb; 48(1):97-102. PubMed ID: 2464193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heredopathia atactica polyneuritiformis (Refsum's disease): 1. Clinical features and dietary management.
    Masters-Thomas A; Bailes J; Billimoria JD; Clemens ME; Gibberd FB; Page NG
    J Hum Nutr; 1980 Aug; 34(4):245-50. PubMed ID: 6157716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phytanic acid on cultured retinal pigment epithelium: an in vitro model for Refsum's disease.
    Bernstein PS; Lloyd MB; O'Day WT; Bok D
    Exp Eye Res; 1992 Dec; 55(6):869-78. PubMed ID: 1283128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of phytanic and linoleic acid into plasma lipids in Refsum's disease.
    Laurell S; Nilsén R; Nordén A
    Clin Chim Acta; 1972 Jan; 36(1):169-74. PubMed ID: 4109168
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on the metabolism of phytol, dihydrophytol and phytanic acid].
    Klenk E; Kremer GJ
    Hoppe Seylers Z Physiol Chem; 1965; 343(1):39-51. PubMed ID: 4161137
    [No Abstract]   [Full Text] [Related]  

  • 39. [Phytanic-acid storage disease: Refsum's syndrome. Heredopathia atactica polyneuritiformis].
    Atzpodien W; Thümler R; Kremer GJ
    Dtsch Med Wochenschr; 1977 Oct; 102(41):1480-4. PubMed ID: 71983
    [No Abstract]   [Full Text] [Related]  

  • 40. [Refsum's disease: evolution 35 years after diagnosis].
    Marcaud V; Defontaines B; Jung P; Degos CF
    Rev Neurol (Paris); 2002 Feb; 158(2):225-9. PubMed ID: 11965181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.